Ignite Creation Date:
2024-05-06 @ 3:23 AM
Last Modification Date:
2024-10-26 @ 11:32 AM
Study NCT ID:
NCT02270359
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-08
First Post:
2014-10-01
Brief Title:
Research on Infarction With Open Arteries Using OCT and CMR
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Study Overview
Official Title:
Research on Infarction With Open Arteries Using OCT and CMR RIO
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RIO
Brief Summary:
The purpose of this study is to determine the prevalence of plaque disruption and to assess the composition of disrupted plaques in patients with myocardial infarction MI and non-obstructive coronary artery disease CAD using optical coherence tomography OCT Additionally cardiac magnetic resonance imaging CMR will be used to detect myocardial abnormalities which will be correlated to OCT findings to gain insight into the mechanisms of MI in patients with non-obstructive coronary artery disease ie open arteries
Detailed Description:
In this single center observational study patients of both sexes with MI who are referred for cath will be enrolled Those who have no obstructive CAD on clinically indicated coronary angiography defined as no stenosis of 50 in any major epicardial vessel will undergo coronary OCT just after the clinically indicated diagnostic angiogram and CMR within 1 week typically within 72-96 hours Participants will be followed for clinical events for at least 1 year 20 fully eligble participants will be recruited at NYU Langone Medical Center and Bellevue Hospital Center among a projected 200 enrolled patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None